Table 5.
Assessments of NO, eNOS, MDA, SOD3, and LVEF in postinfarct rat myocardium.
|
|
Group A |
Group B |
Group C |
Group D |
Group E |
|---|---|---|---|---|---|
| LVEF (%) | 55 ± 5.1 | 30 ± 3.0 | 56 ± 5.3 | 41 ± 4.9∗ | 57 ± 5.8∗∗∗ |
| NO (nmol/mg prot) | 20.5 ± 1.0 | 14.0 ± 0.3 | 21.3 ± 1.1 | 15.9 ± 0.5∗∗ | 18.7 ± 0.8∗∗∗ |
| eNOS (U/mg prot) | 15.3 ± 0.7 | 13.2 ± 0.1 | 16.1 ± 0.9 | 14.8 ± 0.6∗∗ | 16.0 ± 0.7∗∗∗ |
| MDA(nmol/mg prot) | 30.7 ± 23.8 | 60.3 ± 16.1 | 29.5 ± 12.9 | 49.9 ± 15.9∗ | 29.8 ± 14.1∗∗∗ |
| SOD3 (U/mg prot) | 50.9 ± 26.4 | 20.3 ± 14.7 | 51.7 ± 15.9 | 40.2 ± 15.0∗ | 53.1 ± 16.0∗∗∗ |
MDA: malondialdehyde; NO: nitric oxide; eNOS: endothelial nitric oxide synthase; SOD3: superoxide dismutase 3.
∗ P <0.01 (Group B/Group D). ∗∗ P < 0.05 (Group B/Group D). ∗∗∗ P < 0.01 (Group D/Group E).